Gilead Sciences, Inc.

BOVESPA:GILD34 Stock Report

Market Cap: R$460.0b

Gilead Sciences Future Growth

Future criteria checks 1/6

Gilead Sciences is forecast to grow earnings and revenue by 6.5% and 2.3% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 28.9% in 3 years.

Key information

6.5%

Earnings growth rate

7.8%

EPS growth rate

Biotechs earnings growth22.7%
Revenue growth rate2.3%
Future return on equity28.9%
Analyst coverage

Good

Last updated15 Mar 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:GILD34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202628,7627,3139,89110,19022
12/31/202528,0296,8589,4179,65027
12/31/202427,5136,5369,6099,83027
12/31/202327,1165,6657,4218,006N/A
9/30/202327,3915,8767,8538,404N/A
6/30/202327,3825,4848,9269,512N/A
3/31/202327,0435,5838,3868,976N/A
12/31/202227,2814,5928,3449,072N/A
9/30/202227,1363,3349,0079,710N/A
6/30/202227,5154,1379,41510,100N/A
3/31/202227,4724,5159,95310,614N/A
12/31/202127,3056,22510,80511,384N/A
9/30/202127,4827,3949,49110,095N/A
6/30/202126,6385,1628,4729,092N/A
3/31/202125,5643018,6989,342N/A
12/31/202024,6891237,5188,168N/A
9/30/202023,1471,2688,1608,832N/A
6/30/202022,174-2578,5109,227N/A
3/31/202022,7164,9628,2449,003N/A
12/31/201922,4495,3868,3199,144N/A
9/30/201922,3652,6938,0398,909N/A
6/30/201922,3575,9557,6398,476N/A
3/31/201922,3205,8926,7587,707N/A
12/31/201822,1275,4557,4768,400N/A
9/30/201822,2811,5877,9128,808N/A
6/30/201823,1972,2088,4329,290N/A
3/31/201824,6903,46410,55911,243N/A
12/31/201726,1074,62811,30811,898N/A
9/30/201727,47811,601N/A12,684N/A
6/30/201728,46612,213N/A14,383N/A
3/31/201729,10112,637N/A15,842N/A
12/31/201630,39013,501N/A17,047N/A
9/30/201631,57615,076N/A18,382N/A
6/30/201632,37116,346N/A18,085N/A
3/31/201632,83917,341N/A18,758N/A
12/31/201532,63918,108N/A21,250N/A
9/30/201531,44716,912N/A18,476N/A
6/30/201529,19415,043N/A18,424N/A
3/31/201527,48514,207N/A16,951N/A
12/31/201424,89012,101N/A12,818N/A
9/30/201420,6969,406N/A10,524N/A
6/30/201417,4377,463N/A7,233N/A
3/31/201413,6694,580N/A4,001N/A
12/31/201311,2023,075N/A3,105N/A
9/30/201310,5853,046N/A3,084N/A
6/30/201310,2292,933N/A3,076N/A
3/31/20139,8672,872N/A3,414N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GILD34's forecast earnings growth (6.5% per year) is below the savings rate (9.8%).

Earnings vs Market: GILD34's earnings (6.5% per year) are forecast to grow slower than the BR market (14.7% per year).

High Growth Earnings: GILD34's earnings are forecast to grow, but not significantly.

Revenue vs Market: GILD34's revenue (2.3% per year) is forecast to grow slower than the BR market (6.7% per year).

High Growth Revenue: GILD34's revenue (2.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GILD34's Return on Equity is forecast to be high in 3 years time (28.9%)


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.